Building Your Care Team: Specialists and Preparation
At a Glance
Because Kearns-Sayre Syndrome (KSS) affects multiple body systems, patients require a multidisciplinary care team. A neurologist or clinical geneticist typically coordinates care alongside a cardiac electrophysiologist, neuro-ophthalmologist, and endocrinologist to manage the complex symptoms.
Kearns-Sayre Syndrome (KSS) is too complex for any single doctor to manage alone. Because it can affect the heart, brain, eyes, and hormone systems simultaneously, you will need a multidisciplinary care team [1][2].
Think of your care team as an orchestra; while there are many different instruments (specialists), you need a conductor (a lead specialist) to ensure everyone is playing from the same sheet of music [3][4].
Your Core Care Team
Most patients with KSS should be followed by a core group of specialists who understand the unique demands of mitochondrial disease:
- Neurologist or Clinical Geneticist: This doctor often serves as the “quarterback” or lead coordinator. They should have specific expertise in mitochondrial medicine and will manage the overall progression of the disease [5][6].
- Cardiac Electrophysiologist (EP): This is a cardiologist who specializes in the heart’s electrical system. They are the most critical team member for preventing sudden heart block [7][8].
- Neuro-ophthalmologist: A specialist who understands how the brain and eyes work together. They will monitor your pigmentary retinopathy and manage eye muscle weakness (CPEO) [9][10].
- Endocrinologist: This specialist monitors the glands that produce hormones, watching for signs of diabetes, thyroid issues, or calcium regulation problems (hypoparathyroidism) [11][12].
- Genetic Counselor: While KSS is usually sporadic, families often have immense anxiety about inheritance. A counselor is crucial for providing accurate recurrence risks, especially for female patients [13].
Evaluating a Specialist’s Expertise
Because KSS is so rare, you may encounter doctors who have never treated it before. You can evaluate a potential doctor’s expertise by asking targeted questions:
- “How many patients with single large-scale mtDNA deletions have you cared for?” [14].
- “Are you comfortable collaborating with my other specialists to coordinate my care?” [3].
- “What is your experience with the specific risks KSS poses in your field (e.g., heart block in cardiology or retinal atrophy in ophthalmology)?” [7][10].
Preparing for Your First Visit
Mitochondrial clinics often require a significant amount of “hard data” to provide an accurate assessment. Compile a folder (physical or digital) that includes:
Essential Genetic Records
- The full laboratory report from your genetic testing (not just a summary letter). This should detail the size and location of the mitochondrial DNA deletion [15][16].
- If a muscle biopsy was performed, include the pathology report that mentions “ragged red fibers” or other mitochondrial changes [17].
Cardiac and Neurological Data
- Copies of recent EKG strips and Holter monitor reports [7][18].
- A disk containing your most recent brain MRI images (not just the written report) [19][20].
Baseline Lab Results
- Recent blood tests for glucose, calcium, and thyroid-stimulating hormone (TSH) [11][21].
- Results for mitochondrial biomarkers like GDF-15 or FGF-21 if they have been tested [22][23].
Bringing these documents to your first appointment saves time and ensures your new care team has the information they need to protect your health from day one [6][24].
Common questions in this guide
What doctors do I need to see for Kearns-Sayre Syndrome?
What information should I bring to my first mitochondrial clinic visit?
Why does a KSS patient need to see a cardiac electrophysiologist?
How can I tell if a specialist is qualified to treat KSS?
Get notified when new evidence is published on Kearns-Sayre syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (24)
- 1
Mitochondrial diseases in adults.
La Morgia C, Maresca A, Caporali L, et al.
Journal of internal medicine 2020; (287(6)):592-608 doi:10.1111/joim.13064.
PMID: 32463135 - 2
Use of whole genome sequencing to determine genetic basis of suspected mitochondrial disorders: cohort study.
Schon KR, Horvath R, Wei W, et al.
BMJ (Clinical research ed.) 2021; (375()):e066288 doi:10.1136/bmj-2021-066288.
PMID: 34732400 - 3
Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.
Parikh S, Goldstein A, Karaa A, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2017; (19(12)) doi:10.1038/gim.2017.107.
PMID: 28749475 - 4
Diagnostic odyssey of patients with mitochondrial disease: Results of a survey.
Grier J, Hirano M, Karaa A, et al.
Neurology. Genetics 2018; (4(2)):e230 doi:10.1212/NXG.0000000000000230.
PMID: 29600276 - 5
Should Patients with Kearns-Sayre Syndrome and Corneal Endothelial Failure Be Genotyped for a TCF4 Trinucleotide Repeat, Commonly Associated with Fuchs Endothelial Corneal Dystrophy?
Dudakova L, Skalicka P, Davidson AE, et al.
Genes 2021; (12(12)) doi:10.3390/genes12121918.
PMID: 34946867 - 6
Diagnosis, management, and follow-up of mitochondrial disorders in childhood: a personalized medicine in the new era of genome sequence.
Paiva Coelho M, Martins E, Vilarinho L
European journal of pediatrics 2019; (178(1)):21-32 doi:10.1007/s00431-018-3292-x.
PMID: 30535772 - 7
Prophylactic pacemaker placement at first signs of conduction disease in Kearns-Sayre syndrome.
Trivedi M, Goldstein A, Arora G
Cardiology in the young 2018; (28(12)):1487-1488 doi:10.1017/S1047951118001609.
PMID: 30326976 - 8
The necessity of implantable cardioverter defibrillators in patients with Kearns-Sayre syndrome - systematic review of the articles.
Imamura T, Sumitomo N, Muraji S, et al.
International journal of cardiology 2019; (279()):105-111 doi:10.1016/j.ijcard.2018.12.064.
PMID: 30642644 - 9
Teaching NeuroImages: Kearns-Sayre syndrome.
Nguyen MTB, Micieli J, Margolin E
Neurology 2019; (92(5)):e519-e520 doi:10.1212/WNL.0000000000006861.
PMID: 30635486 - 10
Macular findings in Spectral Domain Optical Coherence Tomography and OCT Angiography in a patient with Kearns-Sayre syndrome.
Ortiz A, Arias J, Cárdenas P, et al.
International journal of retina and vitreous 2017; (3()):24 doi:10.1186/s40942-017-0077-8.
PMID: 28702261 - 11
Fatal pneumonia in a patient with Kearns-Sayre syndrome case report and literature review.
Zhang J, Song Z, Zhou H, et al.
Frontiers in medicine 2025; (12()):1575384 doi:10.3389/fmed.2025.1575384.
PMID: 40823579 - 12
Nutritional issues in a diabetic patient with Kearns-Sayre syndrome.
Szwilling A, Dzygalo K, Nowaczyk J
Endocrinology, diabetes & metabolism case reports 2020; (2020()).
PMID: 33434157 - 13
Ophthalmoplegia in Mitochondrial Disease.
Lee SJ, Na JH, Han J, Lee YM
Yonsei medical journal 2018; (59(10)):1190-1196 doi:10.3349/ymj.2018.59.10.1190.
PMID: 30450853 - 14
Kearns-Sayre syndrome: Two case reports and a review for the primary care physician.
Richmond C, Powell L, Brittingham ZD, Mancuso A
Journal of family medicine and primary care 2023; (12(4)):792-795 doi:10.4103/jfmpc.jfmpc_1790_22.
PMID: 37312792 - 15
Whole Mitochondrial Genome Analysis in Turkish Patients with Mitochondrial Diseases
Gencer Öncül EB, Duman D, Eminoğlu FT, et al.
Balkan medical journal 2022; (39(2)):96-106 doi:10.5152/balkanmedj.2021.21141.
PMID: 34928236 - 16
Use of Next-Generation Sequencing for Identifying Mitochondrial Disorders.
Mahmud S, Biswas S, Afrose S, et al.
Current issues in molecular biology 2022; (44(3)):1127-1148 doi:10.3390/cimb44030074.
PMID: 35723297 - 17
Management of Ptosis in Kearns-Sayre Syndrome: A Case Report and Literature Review.
Moustaine MO, Azemour Z, Mohammed F, et al.
Archives of plastic surgery 2024; (51(2)):182-186 doi:10.1055/a-2207-7587.
PMID: 38596148 - 18
Progressive involvement of cardiac conduction system in paediatric patients with Kearns-Sayre syndrome: how to predict occurrence of complete heart block and sudden cardiac death?
Di Mambro C, Tamborrino PP, Silvetti MS, et al.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2021; (23(6)):948-957 doi:10.1093/europace/euaa335.
PMID: 33336258 - 19
Kearns-Sayre syndrome: expanding spectrum of a "novel" mitochondrial leukomyeloencephalopathy.
Moscatelli M, Ardissone A, Lamantea E, et al.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2022; (43(3)):2081-2084 doi:10.1007/s10072-022-05881-8.
PMID: 35031921 - 20
Kearns-Sayre syndrome with restricted diffusion in subcortical white matter and extraocular muscle atrophy.
Matsukawa M, Maeda M, Tanaka F, et al.
Radiology case reports 2025; (20(6)):2646-2650 doi:10.1016/j.radcr.2025.02.088.
PMID: 40151283 - 21
A case of hypopituitarism accompanying Kearns-Sayre syndrome treated with human chorionic gonadotropin: A case report and literature review.
Kang YX, Wang YJ, Zhang Q, et al.
Andrologia 2017; (49(8)) doi:10.1111/and.12711.
PMID: 27709644 - 22
Serum biomarkers in primary mitochondrial disorders.
Varhaug KN, Hikmat O, Nakkestad HL, et al.
Brain communications 2021; (3(1)):fcaa222 doi:10.1093/braincomms/fcaa222.
PMID: 33501425 - 23
Growth and differentiation factor 15 as a biomarker for mitochondrial myopathy.
Poulsen NS, Madsen KL, Hornsyld TM, et al.
Mitochondrion 2020; (50()):35-41 doi:10.1016/j.mito.2019.10.005.
PMID: 31669236 - 24
Understanding the impact of pediatric single large-scale mtDNA deletion syndromes on caregivers: Burdens and challenges.
Chappell M, Parikh S, Reynolds E
JIMD reports 2023; (64(5)):375-386 doi:10.1002/jmd2.12385.
PMID: 37701326
This guide on building a Kearns-Sayre Syndrome care team is for informational purposes only. Always consult your primary physician or geneticist to determine the exact specialists required for your specific medical needs.